Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Activation of Alternate Pro-Survival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts
Qingyu Zhou, Hua Lv, Amin R Mazloom, Huilei Xu, Avi Ma'ayan and James M Gallo
Journal of Pharmacology and Experimental Therapeutics August 6, 2012, jpet.112.196097; DOI: https://doi.org/10.1124/jpet.112.196097
Qingyu Zhou
1 University of South Florida College of Pharmacy;
Hua Lv
2 Mount Sinai School of Medicine
Amin R Mazloom
2 Mount Sinai School of Medicine
Huilei Xu
2 Mount Sinai School of Medicine
Avi Ma'ayan
2 Mount Sinai School of Medicine
James M Gallo
2 Mount Sinai School of Medicine

Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Activation of Alternate Pro-Survival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts
Qingyu Zhou, Hua Lv, Amin R Mazloom, Huilei Xu, Avi Ma'ayan and James M Gallo
Journal of Pharmacology and Experimental Therapeutics August 6, 2012, jpet.112.196097; DOI: https://doi.org/10.1124/jpet.112.196097
Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Activation of Alternate Pro-Survival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts
Qingyu Zhou, Hua Lv, Amin R Mazloom, Huilei Xu, Avi Ma'ayan and James M Gallo
Journal of Pharmacology and Experimental Therapeutics August 6, 2012, jpet.112.196097; DOI: https://doi.org/10.1124/jpet.112.196097
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement